Allergan plc (NYSE:AGN)

153.66
Delayed Data
As of May 24
 -2.29 / -1.47%
Today’s Change
142.81
Today|||52-Week Range
256.80
-6.06%
Year-to-Date

Today’s Trading

Previous close155.95
Today’s open155.85
Day’s range153.51 - 156.45
Volume1,736,530
Average volume (3 months)3,177,995
Market cap$52.3B
Data as of 4:01pm ET, 05/24/2018

Growth & Valuation

Earnings growth (last year)-134.55%
Earnings growth (this year)-2.09%
Earnings growth (next 5 years)+6.90%
Revenue growth (last year)+9.40%
P/E ratioNM
Price/Sales3.43
Price/Book0.74

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca+0.04+0.11%
LLYEli Lilly and Co+0.03+0.04%
ABTAbbott Laboratories+0.67+1.08%
NVONovo Nordisk-0.17-0.35%
Data as of 4:02pm ET, 05/24/2018

Financials

Next reporting dateAugust 22, 2018
EPS forecast (this quarter)$4.08
Annual revenue (last year)$15.9B
Annual profit (last year)-$4.1B
Net profit margin-23.35%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chairman, President &
Chief Executive Officer
Brenton L. Saunders
Executive Vice President-
Global Operations
Wayne R. Swanton
Corporate headquarters
Dublin, Dublin

Forecasts